Please Wait

Applying Filters...

Letermovir
NDC API
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Letermovir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 4 USDMF, 1 EU WC, 1 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 8 FDA Orange Book, 4 Europe, 4 Canada, 2 South Africa

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 13 Disintegrants & Superdisintegrants, 12 Thickeners and Stabilizers, 12 Direct Compression, 10 Granulation, 10 Lubricants & Glidants, 7 Co-Processed Excipients, 7 Coating Systems & Additives, 5 Parenteral, 5 Taste Masking, 4 Film Formers & Plasticizers, 3 Solubilizers, 3 Controlled & Modified Release, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 API Stability Enhancers, 2 Coloring Agents, 2 Rheology Modifiers